Kexing Biopharm Co.,Ltd.

🚀 Exciting Opportunity Alert! 🚀 🎉 We are seeking some highly motivated and experienced talents to lead our marketing strategy and campaigns. 🤝 Come to join our brilliant team! #Kexingbiopharm #Biopharmaceutical #Multiple positions #Colombia #China-Jinan #China-Shenzhen

👏 Exciting news for Shenzhen #Sanctinus Biotechnology Co., Ltd, a wholly-owned subsidiary of #Kexing Biopharm Co.,ltd.! 🎉 Recently, Sanctinus Biotechnology’s main #skincare product, "Recombinant Type III Collagen #Anti-Wrinkle Single Use Essence", has got its first overseas order and will ship to the #Philippines, which marks that Sanctinus Biotechnology has officially embarked on an international journey and opened a new chapter for the Sanctinus brand! 🎉 "Recombinant Type III Collagen Anti-Wrinkle Single Use Essence" is a compound formula comprising multiple nutrients specially designed for reducing dry and fine wrinkles, enhancing skin firmness and hydration efficiency, and improving skin elasticity and brightness. 👏 Sanctinus Biotechnology was founded by a group of scientists returning after more than a decade spent researching and developing recombinant proteins abroad. Driven by a dedication to health and beauty and the spirit of exploration, they have embarked on a quest to unravel the enigma behind youthful, vibrant skin. #Sanctinus #Kexingbiopharm #Type III Collagen #Anti-Wrinkle #skincare #Biotechnology #internationalization

🎉 We just celebrated the #35th Anniversary of #Kexing Biopharm! 🎉 All Kexing people, from Shenzhen Headquarter, Shandong Division and local offices, have witnessed this exciting moment together. Over the 35 years' journey, we have made great achievements and formed our own vibrant culture. Looking into the future, we are seeing a grand blueprint! 🌎 Kexing Biopharm is an innovative #biopharmaceutical enterprise mainly engaged in the R&D, production and sales of recombinant protein drugs and microecological preparations. Focusing on antiviral therapy and the treatment of #tumor, #autoimmune, #kidney disease, #digestive disease and other fields, it is dedicated to building globally leading industrial platforms for new protein, new antibody, nucleic acid and other drugs. It is committed to becoming a leader in high-quality biological drugs and serving global patients. 🌎 Learn more from 💫 https://lnkd.in/gxdg3u4e #Kexingbiopharm #Antitumor #Autoimmune #kidney disease #Biopharmaceutical enterprise

🎉 We are delighted and proud to announce that MHRA has officially granted the Marketing Authorisation for Apexelsin® (Albumin-Bound Paclitaxel) in Great Britain! 🎉 Apexelsin® (Albumin-Bound Paclitaxel) is known for its clinical advantages on improving safety, and patient compliance, which is highly valued in oncology treatment. 🎉 With our high-quality products and dedicated services, we believe we will solve the shortage problem of (Albumin-Bound Paclitaxel) and benefit more patients in UK. 🌎 Kexing Biopharm has been committed to continuing our "Innovation + Internationalization" strategy, aiming to build a robust overseas commercialization platform and serve more patients worldwide. 🌏 Learn more from→https://lnkd.in/gxdg3u4e #Kexingbiopharm #Apexelsin® #Albumin-Bound Paclitaxel #MHRA #Tumor chemotherapy

👏 We are pleased to announce that our strategic cooperation with @Arabian Oasis Holding has reached a new milestone in the short term. We will work together to bring new product options in the immune field to #Saudi Arabia. 👏 Thank you Mr. Sultan El-Ajou, CEO of Arabian Oasis for visiting our booth and communicating with our CEO Mr. Zhao Yanqing on strategic cooperation. We look forward to more cooperation opportunities in the future. #Kexingbiopharm #Arabian Oasis #SaudiArabia #Immune

🎉 #CPHIMilan Day 2 is perfect! ✨ 🎉 A product launch ceremony for #Apexelsin® (Albumin-Bound Paclitaxel) has been held today at our booth-10B10 with great success. 🎉 We are excited to announce that #Kexingbiopharm overseas commercialization has reached a new milestone. The launch of Apexelsin® in Europe will serve more doctors and patients. 🎉 We has been committed to continuing our "Innovation + Internationalization" strategy, aiming to build a robust overseas commercialization platform and serve more patients worldwide. ♥️ Make sure you visit us tomorrow and finish your CPHI experience on an absolute win! #CPHImilan #Kexingbiopharm #Pharmaceuticals #Innovation #GlobalHealth #Paclitaxel #EUApproval #Apexelsin

🌎 CPHI MILAN 2024 warm up ! 🤝 Let’s connect, collaborate and explore new opportunities together. We are thrilled to present and partner at this wonderful trade show. 🤝 Meet us at Hall10-Booth10B10, and we'll be there with a great group of international colleagues, each with extensive expertise in the #Biopharmaceutical industry. 💌 Please contact me via email at sales@kexing.com to schedule a meeting in advance. 📅 See you there. #Kexingbiopharm #Biopharmaceutical #CPHI #MILAN

🎉 🥂 🥂 Warmly celebrate the 75th anniversary of the founding of the People's Republic of China, and wish the motherland prosperity and strength. 🎐 🎐 🎐 Please be informed that our National Day holiday is from October 1st to 7th, and we will resume normal work on October 8th. If you have any questions during the holiday, please email me and I will get back to you as soon as I have an access to emails. 💌 sales@kexing.com

✨ Exciting news! A new product launch from CynbioX, a branch company of Kexing Biopharm ✨ Feel free to contact us → sales@kexing.com

🎉 I can't wait to see you in CPHI Milan. 🎉 We're excited to hold a launch ceremony for #Apexelsin® (Albumin-Bound Paclitaxel) at our booth from 10:30-11:00am on 9th Oct., sincerely inviting you to witness this wonderful moment. 🎉 Let's meet, innovate, and explore the human healthcare. 🎁 See you there. ✨ Event time: 10:30-11:00am ✨ Event date: 9th Oct. 2024 ✨ Booth number: Hall10-10B10 ✨ Location: Fiera Milano, Milan, Italy #Kexingbiopharm #Albumin-Bound Paclitaxel #GMP #CPHI Milan